Scleroderma Market Analysis: Major Players, Lucrative Segments And Top Geographies
27 Nov, 2023
The global scleroderma market is expected to grow from $2 billion in 2022 to $2.15 billion in 2023 at a compound annual growth rate (CAGR) of 7.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The scleroderma market is expected to reach $2.78 billion in 2027 at a CAGR of 6.6%.
Global Scleroderma Market Key Driver
The greater prevalence of scleroderma is propelling the scleroderma market forward. Scleroderma, a chronic autoimmune disease, is characterized by abnormal collagen growth, a protein forming the structure of the skin and other tissues. An unregulated immune response, possibly triggered by various environmental factors, leads to the development of this condition. As the number of cases rises, the significance of improved diagnosis and treatment becomes evident. Scleroderma therapeutics play a crucial role in managing the illness and alleviating symptoms by regulating the immune response and mitigating exposure to environmental risk factors.
Get a sample of the global scleroderma market reportGlobal Scleroderma Market Segments
The global scleroderma market is segmented:
1) By Treatment: Medication; Surgery; Other Treatments
2) By Indication: Systemic Scleroderma; Localized Scleroderma
3) By End User: Hospital; Pharmaceutical Stores; Other End Users
4) By Geography: The regions covered in the scleroderma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global scleroderma market.
Major Scleroderma Industry Players
Scleroderma Market Overview
Scleroderma is a rare, chronic autoimmune disease characterized by the abnormal growth of collagen, a protein that forms the structure of the skin and other tissues. The different treatments cure or halt excessive collagen production, effectively manage symptoms, and reduce the risk of complications associated with scleroderma.
Scleroderma Global Market Report 2023 provides data on the global scleroderma market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The scleroderma market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.